Skip to main content

View full-text article in PMC

. 2021 Jan 15;100(2):e24090. doi: 10.1097/MD.0000000000024090

Table 4.

Clinical characteristics of children using macrolide antibiotics before collection of the samples [cases (%)].

	Macrolide group (n = 119)	Non-Macrolide group (n = 102)	X²	P
Spastic cough	109 (91.76)	91 (89.22)	0.362	.354
Whoop	39 (32.77)	35 (34.31)	0.059	.460
Cyanosis	40 (33.61)	25 (24.51)	2.192	.091
Apnea	13 (10.92)	13 (12.75)	0,175	.416
Fever	29 (24.37)	25 (24.51)	0.001	.552
Rhinorrhea	46 (38.66)	69 (67.65)	3.654	.038
Nasal obstruction	41 (34.45)	31 (30.39)	0.412	.310
Positive bacterial culture	19 (15.97)	40 (39.21)	15.170	.000